|
|
||||||||
| ||||||||||||||||||
| Spot | Coordinate | P | Ratio | SE | Gene Name |
| 764 | D13h | 0.00015865 | 1.9015 | 0.011356 | angiopoietin 1 receptor precursor; tyrosine-protein kinase receptor TIE-2; tyrosine-protein kinase receptor TEK; p140 TEK; tunica interna endothelial cell kinase |
| 570 | C13j | 0.0006393 | 0.62641 | 0.0094506 | transcription factor Sp1 (TSFP1) |
| 858 | E06d | 0.00083246 | 0.66087 | 0.0097909 | growth-arrest-specific protein (GAS) |
| 1128 | F11h | 0.001337 | 0.67249 | 0.011988 | CRM1 protein |
| 1092 | F08n | 0.0014705 | 0.29165 | 0.027194 | BRCA2 region clone CG018 |
| 1050 | F05n | 0.0014818 | 0.39571 | 0.023288 | inducible protein |
| 4 | A01d | 0.0018953 | 1.3663 | 0.015971 | jun-B |
| 750 | D12h | 0.0023235 | 1.508 | 0.02453 | vascular endothelial growth factor receptor 2 precursor (VEGFR2); kinase insert domain receptor (KDR); FLK1 |
| 1021 | F03m | 0.0026433 | 0.59835 | 0.020691 | HEM45 |
| 1138 | F12d | 0.0027066 | 0.66671 | 0.017375 | uridine 5'-monophosphate synthase (UMP synthase) |
| 1154 | F13f | 0.0028389 | 0.33967 | 0.035259 | type II cytoskeletal 4 keratin (KRT4); cytokeratin 4 (K4; CK4) |
| 771 | D14a | 0.0030655 | 0.71678 | 0.015717 | CENP-F kinetochore protein |
| 1085 | F08g | 0.0032744 | 1.6288 | 0.036071 | tubulin gamma subunit |
| 1008 | F02n | 0.0034392 | 0.57964 | 0.024716 | KIAA0137 |
| 479 | C07c | 0.0040484 | 0.71228 | 0.018363 | induced myeloid leukemia cell differentiation protein MCL-1 |
| 249 | B04k | 0.0054851 | 0.42091 | 0.043066 | caveolin-1 |
| 1166 | F14d | 0.0056179 | 0.47424 | 0.039574 | thymidylate kinase |
| 620 | D03d | 0.0056411 | 0.78035 | 0.016567 | cadherin 11 precursor (CDH11); osteoblast-cadherin (OB-cadherin); OSF4 |
| 852 | E05l | 0.0057743 | 1.1124 | 0.0085787 | alpha-2-macroglobulin precursor (alpha-2-M) |
| 1155 | F13g | 0.006178 | 0.67065 | 0.026008 | coronin-like protein P57 |
| 266 | B05n | 0.0069441 | 0.68651 | 0.02626 | signal transducing adaptor molecule (STAM) |
| 967 | E14a | 0.0069656 | 0.41791 | 0.048837 | transforming growth factor beta2 precursor (TGF-beta2; TGFB2); glioblastoma -derived T-cell suppressor factor (G-TSF); bsc-1 cell growth inhibitor; polyergin; cetermin |
| 587 | C14m | 0.0074805 | 0.60146 | 0.034664 | fuse-binding protein 2 (FBP2) |
| 767 | D13k | 0.0078704 | 1.1407 | 0.012553 | butyrophilin precursor (BT) |
| 226 | B03b | 0.0081712 | 1.4178 | 0.038005 | alpha-2-macroglobulin receptor-associated protein precursor (alpha-2-MRAP; A2MRAP); low density lipoprotein receptor-related protein- associated protein 1 (LRPAP1) |
| 182 | A13n | 0.0084942 | 0.76675 | 0.021636 | nucleolar phosphoprotein P130 |
| 191 | A14i | 0.0091736 | 1.8792 | 0.084796 | G1/S-specific cyclin C |
| 1019 | F03k | 0.009201 | 0.71139 | 0.027877 | regulator of G protein signaling 3 (RGS3; RGP3) |
| 1101 | F09i | 0.0097994 | 0.48504 | 0.051355 | arginine/serine-rich splicing factor 8; suppressor of white apricot protein homolog |
| 1157 | F13i | 0.010136 | 0.51381 | 0.049323 | polypyrimidine tract-binding protein (PTB); heterogeneous nuclear ribonucleoprotein I (HNRNP I); 57-kDa RNA-binding protein PPTB-1 |
| 886 | E08d | 0.01081 | 0.47336 | 0.055204 | platelet basic protein precursor (PBP); connective tissue activating peptide III (CTAP III); low-affinity platelet factor IV (LA PF4); beta thromboglobulin (beta TG); neutrophil activating peptide 2 (NAP2) |
| 33 | A03e | 0.011071 | 1.9112 | 0.096677 | vascular endothelial growth factor receptor 1 (VEGFR1); tyrosine-protein kinase receptor flt + soluble VEGFR; tyrosine-protein kinase receptor SFLT |
| 617 | D03a | 0.011986 | 1.4171 | 0.04608 | Ikaros/LyF-1 homolog hIk-1 |
| 1177 | G11 | 0.012043 | 1.3102 | 0.034352 | ubiquitin |
| 489 | C07m | 0.0123 | 0.76317 | 0.02651 | adenovirus E1A enhancer-binding protein; E1A-F; ets translocation variant 4 |
| 990 | F01j | 0.012647 | 0.75886 | 0.027379 | putative RNA-binding protein KOC |
| 909 | E09m | 0.013699 | 0.73817 | 0.030965 | membrane-bound & secreted immunoglobulin gamma heavy chain (IgG3) + immunoglobulin lambda heavy chain (IgG1L) + immunoglobulin kappa heavy chain (IgG1K) + immunoglobulin G1 Fc fragment (IgG1) |
| 760 | D13d | 0.014782 | 0.53928 | 0.056644 | platelet membrane glycoprotein IIIA precursor (GP3A); integrin beta 3 (ITGB3); CD61 antigen |
| 322 | B09n | 0.015413 | 0.79124 | 0.026222 | CD27 ligand (CD27LG); CD70 antigen |
| 431 | C03k | 0.016449 | 0.85705 | 0.018563 | TRAF-interacting protein (I-TRAF) + TRAF family member-associated NF-kappaB activator TANK |
| 1142 | F12h | 0.017037 | 0.61212 | 0.051285 | importin alpha 3 subunit; karyopherin alpha 3 subunit |
| 417 | C02k | 0.018045 | 0.64209 | 0.048741 | ets transcription factor; NERF2 |
| 217 | B02g | 0.018056 | 1.121 | 0.01649 | 3-phosphoinositide-dependent protein kinase 1 (PDK1) |
| 1104 | F09l | 0.018424 | 0.63987 | 0.04957 | KIAA0231 |
| 413 | C02g | 0.018656 | 1.1668 | 0.023104 | DNA ligase III (LIG3); polydeoxyribonucleotide synthase |
| 307 | B08m | 0.019295 | 0.79211 | 0.029303 | segment polarity protein; dishevelled homolog 1 (DSH homolog 1); dishevelled 1 (DVL1) |
| 16 | A02b | 0.020129 | 1.5444 | 0.078424 | EB1 protein |
| 828 | E04b | 0.020284 | 0.47602 | 0.075783 | hepatoma-derived growth factor (HDGF) |
| 844 | E05d | 0.020285 | 0.53862 | 0.066732 | thymus-expressed chemokine precursor (TECK) |
| 23 | A02i | 0.021013 | 1.6593 | 0.097115 | probable G protein-coupled receptor KIAA0001 |
| 383 | B14e | 0.021473 | 1.3528 | 0.052541 | VRK2 |
| 1077 | F07m | 0.021979 | 0.81082 | 0.028519 | interferon-inducible protein 1-8D + 1-8U |
| 809 | E02k | 0.022362 | 1.3865 | 0.058794 | PC8 precursor |
| 687 | D08a | 0.022695 | 0.63862 | 0.055389 | high mobility group protein (HMG-I) |
| 1116 | F10j | 0.024209 | 0.3265 | 0.10674 | suppressor for yeast mutant |
| 1037 | F05a | 0.02545 | 0.53735 | 0.075252 | laminin alpha 4 subunit precursor (laminin A4; LAMA4) |
| 1132 | F11l | 0.026373 | 0.45316 | 0.090606 | ATL-derived PMA-responsive peptide (APR) |
| 1140 | F12f | 0.026543 | 0.36924 | 0.10486 | type II cytoskeletal 2 epidermal keratin (KRT2E); cytokeratin 2E (K2E; CK2E) |
| 1158 | F13j | 0.026573 | 0.62252 | 0.062792 | elongation factor 2 (EF2) |
| 953 | E13a | 0.02659 | 0.77114 | 0.038082 | transforming growth factor-beta (TGF-beta; TGFB) |
| 47 | A04e | 0.028231 | 1.3207 | 0.055057 | tyrosine-protein kinase receptor tyro3 precursor; rse; sky; dtk |
| 470 | C06h | 0.028235 | 0.77683 | 0.038316 | RecQ protein-like (DNA helicase Q1-like) |
| 529 | C10k | 0.028387 | 0.62037 | 0.065361 | signal transducer and activator of transcription 3 (STAT3); acute-phase response factor (APRF) |
| 861 | E06g | 0.02839 | 0.66839 | 0.057098 | interleukin-15 (IL-15) |
| 1107 | F10a | 0.029088 | 0.60807 | 0.068345 | nidogen precursor (NID); entactin |
| 1097 | F09e | 0.029655 | 0.5979 | 0.070829 | adenylosuccinate synthetase; IMP-aspartate ligase |
| 612 | D02j | 0.029765 | 1.4841 | 0.085446 | trk-T3; P68 TRK-T3 oncoprotein |
| 685 | D07m | 0.030499 | 1.922 | 0.16481 | glutathione synthetase (GSH synthetase; GSH-S); glutathione synthase |
| 720 | D10f | 0.030804 | 0.63285 | 0.065973 | zyxin related protein ZRP-1 |
| 27 | A02m | 0.030838 | 0.84213 | 0.028384 | NuMA |
| 691 | D08e | 0.0315 | 0.54682 | 0.082392 | integrin alpha 7B precursor (IGA7B) |
| 1129 | F11i | 0.031516 | 0.72332 | 0.050315 | cleavage stimulation factor 77-kDa subunit |
| 857 | E06c | 0.032938 | 0.69008 | 0.057682 | vascular endothelial growth factor C precursor (VEGF-C); vascular endothelial growth factor related protein (VRP); FLT4 ligand |
| 719 | D10e | 0.033601 | 0.71525 | 0.053555 | semaphorin; CD100 |
| 890 | E08h | 0.033743 | 0.7393 | 0.049142 | jagged 1 (HJ1) |
| 731 | D11c | 0.033967 | 1.1074 | 0.020307 | T-cell surface glycoprotein CD3 epsilon subunit precursor; T-cell surface antigen T3/leu-4 epsilon subunit (T3E) |
| 1133 | F11m | 0.034073 | 0.34461 | 0.12417 | unknown protein expressed in macrophages |
| 1029 | F04g | 0.034215 | 1.3144 | 0.059689 | vimentin (VIM) |
| 995 | F02a | 0.034735 | 0.58328 | 0.079757 | collagen 11 alpha 2 subunit (COL11A2) |
| 903 | E09g | 0.034918 | 0.72638 | 0.052515 | interleukin-16 (IL-16); lymphocyte chemoattractant factor (LCF) |
| 195 | A14m | 0.034966 | 0.55556 | 0.085363 | RBQ-3 |
| 1012 | F03d | 0.03549 | 0.64699 | 0.068334 | thymidylate synthase (TYMS; TS) |
| 845 | E05e | 0.036524 | 0.5108 | 0.096146 | interleukin-1 receptor antagonist protein precursor (IL-1RA; IRAP) |
| 849 | E05i | 0.036681 | 2.7655 | 0.34779 | matrix metalloproteinase 1 (MMP1); interstitial collagenase precursor (CLG); fibroblast collagenase |
| 956 | E13d | 0.038396 | 0.54173 | 0.092482 | fibroblast growth factor 6 precursor (FGF6); HBGF6; HST2 |
| 1067 | F07c | 0.038453 | 0.66226 | 0.068212 | amidophosphoribosyltransferase precursor (ATase); glutamine phosphoribosylpyrophosphate amidotransferase (GPAT) |
| 713 | D09m | 0.038498 | 1.591 | 0.11944 | glutathione-S-transferase (GST) homolog |
| 239 | B04a | 0.0386 | 1.7404 | 0.14984 | ATP synthase coupling factor 6 mitochondrial precursor (F6) |
| 932 | E11h | 0.038641 | 0.39268 | 0.12298 | lunatic fringe |
| 379 | B14a | 0.038702 | 1.2441 | 0.049475 | integrin-linked kinase (ILK) |
| 1105 | F09m | 0.040559 | 0.65969 | 0.070706 | hypothetical 120.4-kDa protein |
| 957 | E13e | 0.040922 | 0.43965 | 0.11698 | CD30 ligand (CD30L); CD153 antigen |
| 404 | C01l | 0.041316 | 0.77934 | 0.0463 | zinc finger 5 protein |
| 811 | E02m | 0.041659 | 0.47687 | 0.11025 | MHC class I truncated HLA G lymphocyte antigen + HLA class I histocompability antigen AW-80(A-1) alpha chain precursor + MHC class I antigen HLA-B + MHC class I antigen HLA-C |
| 173 | A13e | 0.041954 | 1.4845 | 0.10248 | transforming protein rhoA H12 (RHO12; ARH12; ARHA) |
| 855 | E06a | 0.042752 | 0.36369 | 0.13597 | bone morphogenetic protein 4 (BMP4) + bone morphogenetic protein 2B (BMP2B) |
| 758 | D13b | 0.043076 | 0.77976 | 0.047251 | platelet glycoprotein IV (GPIV; PAS IV; PAS4); GPIIIB; CD36 antigen |
| 78 | A06h | 0.043191 | 1.4091 | 0.087897 | notch4; hnotch4 |
| 662 | D06d | 0.043331 | 1.1721 | 0.037037 | integrin alpha E precursor (ITGAE); mucosal lymphocyte-1 antigen; hml-1 antigen; CD103 antigen |
| 1176 | F14n | 0.043778 | 0.51012 | 0.10601 | antigen KI-67 (MKI67) |
| 252 | B04n | 0.043832 | 0.63885 | 0.078206 | B-cell receptor-associated protein (hBAP) |
| 402 | C01j | 0.044566 | 0.73537 | 0.057816 | ets domain protein elk-3; NET; SRF accessory protein 2 (SAP2) |
| 929 | E11e | 0.044749 | 0.68094 | 0.069861 | SCGF-beta |
| 991 | F01k | 0.045141 | 0.86294 | 0.030152 | 60S ribosomal protein L10; tumor suppressor QM; laminin receptor homolog |
| 734 | D11f | 0.045435 | 0.72698 | 0.06027 | ninjurin-1 |
| 1072 | F07h | 0.046355 | 1.1794 | 0.040022 | GTP-binding nuclear protein RAN (TC4) |
| 1152 | F13d | 0.046876 | 0.64359 | 0.080006 | adenylate kinase isoenzyme 1 (AK1); ATP-AMP transphosphorylase; myokinase |
| 653 | D05i | 0.047073 | 0.79186 | 0.046828 | fibroblast growth factor receptor 3 precursor (FGFR3); JTK4 + fibroblast growth factor receptor 2 precursor (FLG2) |
| 1169 | F14g | 0.047463 | 0.52671 | 0.10696 | microtubule-associated protein 1B |
| 1114 | F10h | 0.04756 | 0.59387 | 0.09188 | dual-specificty A-kinase anchoring protein 1 |
| 121 | A09i | 0.048128 | 1.7841 | 0.17852 | G1/S-specific cyclin E (CCNE) |
| 1121 | F11a | 0.048181 | 0.59416 | 0.092459 | tenascin precursor (TN); hexabrachion (HXB); cytotactin; neuronectin; GMEM; miotendinous antigen; glioma-associated extracellular matrix antigen |
| 707 | D09g | 0.04883 | 0.8305 | 0.038894 | protocadherin 43 precursor (PCDH43); cadherin-like protein |
| 805 | E02g | 0.048897 | 0.63606 | 0.083574 | interleukin-14 precursor (IL-14); high molecular weight B-cell growth factor (HMW-BCGF) |
| 882 | E07n | 0.049925 | 0.69362 | 0.071149 | procollagen 2 alpha 1 subunit precursor (COL2A1) |
| 240 | B04b | 0.050206 | 1.4337 | 0.10103 | APS |
| 1134 | F11n | 0.05022 | 0.37372 | 0.1459 | MYD88 |
| 919 | E10i | 0.050759 | 0.51903 | 0.1127 | matrix metalloproteinase 9 (MMP9); gelatinase B; 92-kDa type IV collagenase precursor (CLG4B) |
| 842 | E05b | 0.050953 | 0.51612 | 0.11361 | endothelin 3 (EDN3; ET3) |
| 490 | C07n | 0.050999 | 0.58826 | 0.096724 | AP4 basic helix-loop-helix DNA-binding protein |
| 642 | D04l | 0.05144 | 1.9288 | 0.21921 | low-density lipoprotein receptor-related protein LR11 precursor |
| 1170 | F14h | 0.052577 | 0.71108 | 0.069 | nuclear pore complex protein 153 (NUP153); 153-kDa nucleoporin |
| 185 | A14c | 0.052598 | 1.6606 | 0.15779 | ets-related protein tel; ets translocation variant 6 (ETV6) |
| 158 | A12d | 0.052738 | 1.4973 | 0.11897 | epidermal growth factor receptor (EGFR) |
| 339 | B11c | 0.053187 | 1.1145 | 0.027507 | C-jun N-terminal kinase 3 alpha2 (JNK3A2); PRKM10 + MAP kinase p493F12 |
| 532 | C10n | 0.053349 | 0.66711 | 0.080132 | myeloid ELF1-like factor |
| 35 | A03g | 0.054322 | 1.2187 | 0.053165 | c-myc binding protein MM-1 |
| 780 | D14j | 0.054325 | 1.8538 | 0.20754 | interleukin-13 receptor |
| 569 | C13i | 0.05465 | 0.65819 | 0.083364 | hypoxia-inducible factor 1 alpha (HIF1 alpha); ARNT-interacting protein; member of PAS protein 1 (MOP1) |
| 510 | C09f | 0.054887 | 0.63889 | 0.088277 | DNA topoisomerase II beta (TOP2B) |
| 45 | A04c | 0.054954 | 1.6416 | 0.15696 | c-rel proto-oncogene protein |
| 813 | E03a | 0.055149 | 0.65942 | 0.083474 | bone morphogenetic protein 1 (BMP1) + procollagen C-proteinase (pCP-2) |
| 1118 | F10l | 0.055405 | 0.47104 | 0.12997 | KIAA0265 |
| 674 | D07b | 0.056834 | 0.57578 | 0.10569 | high mobility group protein HMG2 |
| 1044 | F05h | 0.056999 | 1.2638 | 0.065818 | interferon-regulated resistance GTP-binding protein MXA (IFI-78K); interferon- induced protein P78 |
| 370 | B13f | 0.057013 | 0.88897 | 0.02771 | serine kinase SRPK2 |
| 546 | C11n | 0.057143 | 0.54868 | 0.11278 | transcription factor HGATA-6 |
| 294 | B07n | 0.058007 | 0.5411 | 0.11562 | fas antigen ligand (FASL); apoptosis antigen ligand (APTL; APT1LG1); TNFSF6 |
| 851 | E05k | 0.059349 | 1.7356 | 0.18765 | oxytocinase; cystinyl aminopeptidase |
| 170 | A13b | 0.059975 | 1.2795 | 0.071714 | p78 putative serine/threonine-protein kinase |
| 123 | A09k | 0.060124 | 0.92294 | 0.0198 | CDC-like kinase 3 (CLK3) |
| 1036 | F04n | 0.060597 | 0.67499 | 0.083867 | KIAA0279 |
| 140 | A10n | 0.061553 | 0.63461 | 0.0951 | btg protein precursor; NGF-inducible anti-proliferative protein PC3 |
| 884 | E08b | 0.061775 | 0.54827 | 0.11781 | amphiregulin (AR); colorectum cell-derived growth factor (CRDGF) |
| 1131 | F11k | 0.062634 | 0.5707 | 0.11281 | ribosomal protein S21 (RPS21) |
| 416 | C02j | 0.063421 | 0.69657 | 0.080284 | RBP2 retinoblastoma binding protein |
| 1110 | F10d | 0.063943 | 0.60943 | 0.10381 | ribonucleoside-diphosphate reductase M1 subunit; ribonucleotide reductase |
| 712 | D09l | 0.06431 | 1.5849 | 0.15595 | protein tyrosine phosphatase |
| 508 | C09d | 0.06474 | 0.76375 | 0.063224 | ionizing radiation resistance-conferring protein + death-associated protein 3 (DAP3) |
| 901 | E09e | 0.065112 | 0.49487 | 0.13561 | macrophage inhibitory cytokine 1 (MIC1) |
| 367 | B13c | 0.065425 | 1.1501 | 0.040401 | histamine H1 receptor (HRH1) |
| 1026 | F04d | 0.065726 | 1.522 | 0.14087 | purine nucleoside phosphorylase (PNP); inosine phosphorylase |
| 969 | E14c | 0.065912 | 0.56161 | 0.11849 | glia maturation factor beta (GMF-beta) |
| 474 | C06l | 0.066215 | 0.84057 | 0.043201 | signal transducer and transcription activator 5A (STAT5A) + signal transducer and transcription activator 5B (STAT5B) |
| 475 | C06m | 0.066526 | 0.64119 | 0.09748 | B4-2 protein |
| 588 | C14n | 0.066959 | 0.7446 | 0.069636 | transcription factor erf-1; AP2 gamma transcription factor |
| 756 | D12n | 0.067179 | 0.81715 | 0.049946 | semaphorin E |
| 963 | E13k | 0.067523 | 0.60777 | 0.10744 | tissue-type plasminogen activator precursor (T-plasminogen activator; TPA) |
| 448 | C04n | 0.06767 | 1.5532 | 0.15171 | PIRIN |
| 906 | E09j | 0.067816 | 1.4347 | 0.11937 | placental plasminogen activator inhibitor 2 (PAI-2; PLANH2); monocyte ARG-serpin; urokinase inhibitor |
| 518 | C09n | 0.068464 | 0.8109 | 0.052197 | acid finger protein |
| 934 | E11j | 0.069487 | 0.81434 | 0.051672 | tissue inhibitor of metalloproteinases 2 (TIMP2); metalloproteinase inhibitor 2 precursor; CSC-21K |
| 911 | E10a | 0.07073 | 0.67472 | 0.091433 | bone-derived growth factor 1 (BPGF1) |
| 972 | E14f | 0.071604 | 0.63189 | 0.10418 | interleukin-10 precursor (IL-10); cytokine synthesis inhibitory factor (CSIF) |
| 1109 | F10c | 0.072214 | 0.56304 | 0.12426 | inosine-5'-monophosphate dehydrogenase 2 (IMP dehydrogenase 2; IMPD2) |
| 115 | A09c | 0.07257 | 1.3539 | 0.10093 | jun-D |
| 30 | A03b | 0.073371 | 0.79335 | 0.05929 | ezrin; cytovillin 2; villin 2 (VIL2) |
| 1054 | F06d | 0.073417 | 0.80442 | 0.056133 | L-lactate dehydrogenase H subunit (LDHB) |
| 601 | D01m | 0.073635 | 1.2621 | 0.075335 | transmembrane protein sex precursor |
| 488 | C07l | 0.073923 | 0.80966 | 0.054839 | CHD3 |
| 145 | A11e | 0.074703 | 2.177 | 0.34112 | C-fgr proto-oncogene (p55-FGR); SRC2 |
| 476 | C06n | 0.074811 | 0.54236 | 0.13274 | interferon regulatory factor 3 (IRF3) |
| 711 | D09k | 0.075243 | 1.7004 | 0.2038 | eph-family protein |
| 1185 | G47 | 0.076653 | 0.50219 | 0.14638 | 40S ribosomal protein S9 |
| 1040 | F05d | 0.07668 | 0.65105 | 0.10263 | L-lactate dehydrogenase M subunit (LDHA) |
| 1130 | F11j | 0.076801 | 0.6084 | 0.11527 | eukaryotic translation initiation factor 4E 25-kDa subunit (EIF4E); mRNA cap-binding protein |
| 1126 | F11f | 0.077053 | 0.77348 | 0.066802 | type II cytoskeletal 2 oral keratin; cytokeratin 2P (K2P; CK2P) |
| 1035 | F04m | 0.077711 | 0.71485 | 0.084498 | polyhomeotic 2 homolog (HPH2) |
| 692 | D08f | 0.078175 | 0.62734 | 0.1108 | paxillin |
| 654 | D05j | 0.078238 | 0.69266 | 0.09142 | interferon-alpha/beta receptor beta subunit precursor (IFN-alpha-R); type I interferon receptor (IFN-R) |
| 785 | E01a | 0.078786 | 0.6181 | 0.11405 | semaphorin-1 |
| 989 | F01i | 0.079083 | 0.84706 | 0.045769 | nuclear pore complex protein 358 (NUP153); 358-kDa nucleoporin; RAN-binding protein 2 |
| 211 | B02a | 0.080024 | 1.3074 | 0.092625 | ADP/ATP carrier protein |
| 280 | B06n | 0.080252 | 0.66936 | 0.099773 | CD40 ligand (CD40-L); tumor necrosis factor (TNF)-related activation protein (TRAP); T-cell antigen GP39 |
| 1103 | F09k | 0.081368 | 0.69166 | 0.093776 | aspartyl-tRNA synthetase (ASPRS); aspartate-tRNA ligase |
| 753 | D12k | 0.083632 | 0.58035 | 0.12964 | G protein-coupled receptor GPR-NGA |
| 231 | B03g | 0.083694 | 1.805 | 0.24877 | serum- & glucocorticoid-regulated serine/threonine protein kinase (SGK) |
| 702 | D09b | 0.084123 | 1.9898 | 0.30678 | nuclear protein |
| 1055 | F06e | 0.086354 | 1.1874 | 0.058962 | trifunctional purine biosynthetic protein adenosine 3 |
| 134 | A10h | 0.086652 | 1.9819 | 0.30954 | von Hippel-Lindau-binding protein 1 (HIBBJ46; VHL-binding protein 1; VBP1) |
| 945 | E12g | 0.086977 | 0.72801 | 0.085924 | eph-related receptor tyrosine kinase ligand 1 precursor (EPGL1); LERK-1; immediate early response protein B61; tumor necrosis factor-alpha (TNF-alpha)-induced protein 4 (TNFAIP4) |
| 19 | A02e | 0.08719 | 1.4278 | 0.13533 | platelet-derived growth factor receptor alpha subunit (PDGFRA); CD140A antigen |
| 574 | C13n | 0.087459 | 0.51535 | 0.15359 | basic-leucine zipper transcription factor MAFG |
| 710 | D09j | 0.087492 | 0.64063 | 0.11391 | G protein-coupled receptor EDG4 |
| 988 | F01h | 0.087501 | 0.82021 | 0.056992 | erythrocyte spectrin alpha subunit |
| 799 | E02a | 0.087572 | 0.52574 | 0.15041 | bone morphogenetic protein 3B precursor (BMP3B); growth differentiation factor 10 (GDF10); bone inducing protein (BIP) |
| 1096 | F09d | 0.088241 | 0.73646 | 0.083946 | 5'-nucleotidase precurso (5'-NT)r; ecto-nucleotidase; CD73 antigen |
| 936 | E11l | 0.088681 | 1.4616 | 0.14747 | CD59 glycoprotein precursor; membrane attack complex inhibition factor (MACIF); MAC inhibitory protein (MACIP); MEM43 antigen; protectin; membrane inhibitor of reactive lysis (MIRL); HRF20; 1F5 antigen |
| 350 | B11n | 0.088778 | 0.5844 | 0.13285 | secreted apoptosis related protein 1 (SARP1) |
| 535 | C11c | 0.089841 | 1.1455 | 0.046841 | Fas-activated serine/threonine (FAST) kinase |
| 1032 | F04j | 0.090977 | 1.2834 | 0.09187 | cofactor C |
| 449 | C05a | 0.092758 | 0.60337 | 0.13002 | death receptor 5 (DR5); cytotoxic TRAIL receptor 2 (TRICK2A) |
| 832 | E04f | 0.093515 | 0.48246 | 0.17046 | interleukin-7 (IL-7) |
| 251 | B04m | 0.094073 | 0.74288 | 0.084979 | SH3P17 SH3 domain-containing protein |
| 491 | C08a | 0.094719 | 1.8064 | 0.26759 | receptor interacting protein; serine/threonine protein kinase RIP transferase; serine/threonine-protein kinase ATP-binding apoptosis; cell death protein RIP |
| 1099 | F09g | 0.095447 | 1.5977 | 0.19923 | gravin |
| 17 | A02c | 0.097258 | 1.3652 | 0.12306 | myb proto-oncogene; c-myb |
| 436 | C04b | 0.097835 | 0.95553 | 0.015035 | tumor necrosis factor type 1 receptor associated protein (TRAP1) |
| 79 | A06i | 0.099225 | 1.5274 | 0.17979 | G1/S-specific cyclin D1 (CCND1); cyclin PRAD1; bcl-1 oncogene |
| 808 | E02j | 0.099503 | 1.7947 | 0.27138 | microsomal aminopeptidase N; myeloid plasma membrane glycoprotein CD13 |
| 639 | D04i | 0.10001 | 0.61582 | 0.13158 | ephrin type-A receptor 2 precursor; epithelial cell kinase (ECK); tyrosine-protein kinase receptor ECK |
| 598 | D01j | 0.10016 | 2.0158 | 0.34821 | patched homolog (PTC) |
| 224 | B02n | 0.1007 | 0.64831 | 0.12093 | pituitary adenylate cyclase activating polypeptide I receptor precursor (PACAP I receptor; PACAPR1; ADCYAP1R1) |
| 659 | D06a | 0.10116 | 0.69773 | 0.10422 | guanine nucleotide-binding protein G(Y) alpha 11 subunit (GNA11; GA11) |
| 983 | F01c | 0.10123 | 1.2035 | 0.0702 | uroporphyringen III synthase |
| 525 | C10g | 0.10169 | 1.1484 | 0.051307 | DNA mismatch repair protein PMS1 (PMS1 protein homolog 1) |
| 536 | C11d | 0.10184 | 1.2719 | 0.094113 | inhibitor of apoptosis protein 2 (HIAP2; IAP2) + IAP homolog B; TNFR2-TRAF signalling complex protein 2; MIHB |
| 876 | E07h | 0.10211 | 0.53368 | 0.16167 | macrophage migration inhibitory factor (MIF); glycosylation-inhibiting factor (GIF) |
| 607 | D02e | 0.1026 | 1.3061 | 0.10641 | integrin beta 6 precursor (ITGB6) |
| 159 | A12e | 0.10355 | 1.7576 | 0.26481 | shb proto-oncogene |
| 1102 | F09j | 0.1044 | 0.53976 | 0.16165 | "CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase; beta-galactoside alpha-2,3-sialyltransferase (alpha-2,3-ST); sialyltransferase 4A (SIAT4A)" |
| 142 | A11b | 0.10533 | 1.2615 | 0.09233 | TSG101 tumor susceptibility protein |
| 484 | C07h | 0.10542 | 0.72063 | 0.098687 | KIAA0078 |
| 1069 | F07e | 0.10563 | 0.6081 | 0.1386 | ribonucleoside-diphosphate reductase M2 subunit; ribonucleotide reductase |
| 594 | D01f | 0.10579 | 1.4251 | 0.15047 | RP105 |
| 1006 | F02l | 0.10624 | 0.54856 | 0.1602 | leukocyte interferon-inducible peptide |
| 626 | D03j | 0.10758 | 2.1371 | 0.40653 | interleukin-6 receptor alpha subunit precursor (IL-6R-alpha; IL6R); CD126 antigen |
| 203 | B01g | 0.10789 | 1.4204 | 0.15056 | CDC7-related kinase |
| 583 | C14i | 0.10792 | 0.85856 | 0.050663 | jun activation domain binding protein |
| 892 | E08j | 0.10817 | 1.3002 | 0.10769 | endothelial plasminogen activator inhibitor-1 precursor (PAI1; PLANH1) |
| 994 | F01n | 0.10853 | 0.64507 | 0.12755 | septin 2 homolog; KIAA0128 |
| 176 | A13h | 0.10989 | 1.3234 | 0.11708 | active breakpoint cluster region-related protein |
| 735 | D11g | 0.11037 | 0.78884 | 0.076647 | envoplakin (EVPL) |
| 147 | A11g | 0.11082 | 1.5286 | 0.19235 | PIG7 |
| 472 | C06j | 0.11097 | 0.80397 | 0.071386 | PRB-binding protein E2F1; retinoblastoma-binding protein 3 (RBBP3); retinoblastoma-associated protein 1 (RBAP1); PBR3 |
| 680 | D07h | 0.11106 | 0.70611 | 0.10707 | CDW40 antigen; CD40L receptor precursor; nerve growth factor receptor-related B-lymphocyte activation molecule |
| 1127 | F11g | 0.11248 | 0.78422 | 0.079217 | restin; cytoplasmic linker protein 170 alpha ) (CLIP170); Reed-Sternberg intermediate filament-associated protein |
| 336 | B10n | 0.11263 | 0.78632 | 0.078506 | secreted apoptosis related protein 3 (SARP3) |
| 108 | A08j | 0.11266 | 1.1489 | 0.054696 | extracellular signal-regulated kinase 1 (ERK1; p44-ERK1); microtubule-associated protein 2 kinase; insulin-stimulated MAP2 kinase; MAP kinase 1 (MAPK1; p44-MAPK); PRKM3 |
| 952 | E12n | 0.113 | 0.70599 | 0.10823 | collagen 6 alpha 2 subunit (COL6A2) |
| 655 | D05k | 0.11412 | 2.0062 | 0.3726 | colon carcinoma kinase 4 precursor (CCK4) + transmembrane receptor PTK7 |
| 1182 | G31 | 0.1147 | 0.58618 | 0.1537 | HLA class I histocompatibility antigen C-4 alpha subunit (HLAC) |
| 354 | B12d | 0.11568 | 1.2116 | 0.079012 | focal adhesion kinase 2 (FADK2; FAK2); cell adhesion kinase beta (CAKbeta); proline-rich tyrosine kinase 2 (PYK2) |
| 717 | D10c | 0.11671 | 1.2946 | 0.11056 | T-cell surface glycoprotein CD8 beta.1 subunit precursor |
| 648 | D05d | 0.11678 | 0.79728 | 0.076112 | cadherin 8 (CDH8) |
| 273 | B06g | 0.1176 | 1.1588 | 0.059869 | protein tyrosine kinase |
| 73 | A06c | 0.11771 | 1.3269 | 0.12332 | N-myc proto-oncogene |
| 943 | E12e | 0.11875 | 0.50812 | 0.18655 | sonic hedgehog (SHH) |
| 363 | B12m | 0.11888 | 0.72504 | 0.10434 | guanylate kinase (GMP kinase) |
| 52 | A04j | 0.11898 | 0.81639 | 0.069713 | cell division protein kinase 4; cyclin-dependent kinase 4 (CDK4); PSK-J3 |
| 124 | A09l | 0.1193 | 1.49 | 0.18634 | cyclin-dependent kinase inhibitor 1 (CDKN1A); melanoma differentiation-associated protein 6 (MDA6); CDK-interacting protein 1 (CIP1); WAF1 |
| 335 | B10m | 0.12029 | 0.57587 | 0.16211 | junction plakoglobin (JUP); desmoplakin III (DP3) |
| 1051 | F06a | 0.12121 | 0.63562 | 0.13992 | laminin beta 2 subunit precursor (laminin B2; LAMB2); S-laminin |
| 788 | E01d | 0.12138 | 0.6532 | 0.13328 | ciliary neuronotrophic factor (CNTF) isoforms B & C |
| 53 | A04k | 0.12209 | 1.116 | 0.044754 | stem cell tyrosine kinase 1 (STK1); FL cytokine receptor precursor; tyrosine-protein kinase receptor flt3; CD135 antigen |
| 970 | E14d | 0.12451 | 0.61377 | 0.15074 | fibroblast growth factor 8 (FGF8); androgen-induced growth factor precursor (AIGF); HBGF8 |
| 944 | E12f | 0.12518 | 0.63846 | 0.14157 | interferon-beta (IFN-beta; IFNB); fibroblast interferon |
| 100 | A08b | 0.12528 | 1.4731 | 0.18535 | mothers against dpp homolog 4 (SMAD4); MADR4; pancreatic carcinoma gene 4 (DPC4) |
| 1175 | F14m | 0.12611 | 0.58471 | 0.16336 | clone PO2ST9 (brain striatum) |
| 101 | A08c | 0.12615 | 1.4375 | 0.17211 | MAD protein; MAX dimerizer |
| 423 | C03c | 0.12691 | 1.1997 | 0.078849 | bcl2 homologous antagonist/killer (BAK) |
| 11 | A01k | 0.1272 | 1.5521 | 0.21832 | wee1Hu CDK tyrosine 15-kinase; wee-1-like protein kinase |
| 872 | E07d | 0.12758 | 0.63393 | 0.14502 | vascular endothelial growth factor B precursor (VEGFB) + VEGF-related factor isoform VRF186 |
| 415 | C02i | 0.12799 | 1.2559 | 0.10156 | G/T mismatch-specific thymine DNA glycosylase (TDG) |
| 1148 | F12n | 0.12852 | 0.64199 | 0.14247 | clone 23815 (Soares library 1NIB from IMAGE Consortium) |
| 947 | E12i | 0.12949 | 0.71387 | 0.11438 | matrix metalloproteinase 14 precursor (MMP14); membrane-type matrix metalloproteinase 1 (MT-MMP1); MMP-X1 |
| 630 | D03n | 0.13073 | 0.79469 | 0.082561 | (2'-5')oligoadenylate synthetase 2 ((2-5')oligo(A) synthetase 2; 2-5A synthetase 2) |
| 132 | A10f | 0.13368 | 1.2928 | 0.11936 | matrix metalloproteinase 11 (MMP11); stromelysin 3 |
| 624 | D03h | 0.134 | 1.4862 | 0.19853 | guanine nucleotide-binding protein G(K) alpha 3 subunit (GNA3) |
| 897 | E09a | 0.1344 | 0.84007 | 0.06542 | bone morphogenetic protein 8 (BMP8; osteogenic protein 2 (OP2) |
| 172 | A13d | 0.13714 | 1.4235 | 0.1754 | ERBB2 receptor protein-tyrosine kinase; neu proto-oncogene; c-erbB2 + HER2 receptor |
| 1025 | F04c | 0.13748 | 1.2183 | 0.090568 | deoxycytidine kinase |
| 1137 | F12c | 0.13752 | 0.76912 | 0.095793 | bifunctional purine biosynthesis protein |
| 103 | A08e | 0.13766 | 1.5371 | 0.223 | C-src proto-oncogene (SRC1) |
| 765 | D13i | 0.13793 | 0.78995 | 0.087316 | 70-80-kDa transforming growth factor beta receptor II |
| 377 | B13m | 0.13853 | 0.73511 | 0.11041 | GRB2-associated binder 1 (GAB1) |
| 184 | A14b | 0.1389 | 2.2711 | 0.53068 | c-fos proto-oncogene; G0S7 protein |
| 792 | E01h | 0.13908 | 1.29 | 0.12119 | ephrin-B2 precursor; EPH-related receptor tyrosine kinase ligand 5 (LERK-5); HTK ligand (HTK-L) |
| 958 | E13f | 0.13977 | 0.5149 | 0.20333 | interferon-alpha2 precursor (IFN-alpha; IFNA); leukocyte interferon-alphaA (LEIF A); roferon + IFN-alpha10 precursor; LEIF C; IFN-alpha-6L |
| 1083 | F08e | 0.14013 | 0.79465 | 0.08621 | adenylate kinase 3 (AK3); mitochondrial GTP:AMP phosphotransferase |
| 609 | D02g | 0.14022 | 0.68367 | 0.13285 | osteoblast specific factor 2 (OSF2); OSF-2P1 |
| 1149 | F13a | 0.1405 | 1.1945 | 0.081798 | versican core protein precursor; large fibroblast proteoglycan; chondroitin sulfate proteoglycan core protein 2; glial hyaluronate-binding protein (GHAP) |
| 7 | A01g | 0.14063 | 1.7023 | 0.29549 | 5T4 oncofetal antigen precursor |
| 54 | A04l | 0.14183 | 0.84438 | 0.065829 | cell division protein kinase 8 (CDK8); protein kinase K35 |
| 745 | D12c | 0.14207 | 0.70653 | 0.12427 | T-cell surface glycoprotein CD5 precursor; lymphocyte glycoprotein T1/leu-1 |
| 941 | E12c | 0.14231 | 0.76137 | 0.10116 | delta-like protein precursor (DLK) |
| 984 | F01d | 0.14276 | 0.78802 | 0.090038 | xanthine dehydrogenase/oxidase |
| 865 | E06k | 0.14363 | 1.5183 | 0.221 | ubiquitin thiolesterase X-linked fat facets protein related (FAF-X); USP9; ubiquitin-specific processing protease; deubiquitinating enzyme; DFFRX + ubiquitin thiolesterase Y-linked fat facets protein related (FAF-Y); USP10; DFFRY |
| 466 | C06d | 0.14372 | 0.87034 | 0.055302 | sentrin; ubiquitin-like protein SMT3C; ubiquitin-homology domain protein PIC1; UBL1; SUMO-1; GAP modifying protein 1; GMP1 |
| 246 | B04h | 0.14484 | 1.3905 | 0.16737 | protein kinase DYRK2 |
| 154 | A11n | 0.14867 | 0.81123 | 0.082255 | regulator of chromosome condensation; cell cycle regulatory protein |
| 1106 | F09n | 0.14963 | 0.59428 | 0.17751 | mitogen-responsive phosphoprotein DOC2 |
| 1141 | F12g | 0.15238 | 0.73177 | 0.11873 | BCL7B protein |
| 287 | B07g | 0.1527 | 1.0875 | 0.038787 | skeletal muscle phosphorylase B kinase gamma catalytic subunit |
| 973 | E14g | 0.1539 | 0.83153 | 0.075047 | ephrin-B1 precursor; eph-related receptor tyrosine kinase ligand 2 (LERK-2); ELK ligand precursor (ELK-L) |
| 913 | E10c | 0.1548 | 0.68443 | 0.1411 | placenta growth factors 1 + 2 (PLGF1 + PLGF2 ) |
| 1 | A01a | 0.15597 | 1.4602 | 0.20677 | adenomatous polyposis coli protein (APC protein); DP2.5 |
| 210 | B01n | 0.15607 | 0.73951 | 0.11709 | CRK-like protein |
| 107 | A08i | 0.15631 | 1.6279 | 0.28251 | G1/S-specific cyclin D3 (CCND3) |
| 186 | A14d | 0.15696 | 2.0644 | 0.48017 | ERBB-3 receptor protein-tyrosine kinase precursor; epidermal growth factor receptor |
| 665 | D06g | 0.1575 | 1.165 | 0.07461 | cadherin 13 (CDH13); truncated cadherin precursor (T-cadherin); heart cadherin (H-cadherin) |
| 26 | A02l | 0.1581 | 1.2688 | 0.12183 | extracellular signal-regulated kinase 6 (ERK6); stress-activated protein kinase-3; mitogen-activated protein kinase p38 gamma; (MAP kinase p38 gamma) |
| 83 | A06m | 0.15829 | 1.2543 | 0.11536 | cell cycle progression 2 protein (CPR2) |
| 761 | D13e | 0.15846 | 0.60265 | 0.18036 | garp protein precursor; garpin |
| 555 | C12i | 0.15856 | 0.58194 | 0.18984 | TIS11B protein; EGF response factor 1 (ERF1) |
| 1059 | F06i | 0.1587 | 1.8096 | 0.36785 | protein P84 |
| 549 | C12c | 0.15973 | 0.71988 | 0.1278 | rac-alpha serine/threonine kinase (rac-PK-alpha); protein kinase B (PKB); c-akt; akt1 |
| 155 | A12a | 0.15979 | 1.3426 | 0.15637 | putative protein-tyrosine phosphatase PTEN; mutated in multiple advanced cancers 1 |
| 6 | A01f | 0.15993 | 1.6199 | 0.28305 | transforming protein p21/K-ras 2B |
| 451 | C05c | 0.16513 | 1.239 | 0.11141 | apoptosis regulator bcl-2 |
| 997 | F02c | 0.16564 | 0.85051 | 0.069837 | methylenetetrahydrofolate dehydrogenase- methylenetetrahydrofolate cyclohydrolase-formyltetrahydrofolate synthetase |
| 1161 | F13m | 0.16579 | 0.64347 | 0.16665 | P18 protein |
| 114 | A09b | 0.16631 | 1.77 | 0.36064 | c-myc purine-binding transcription factor puf; nucleoside diphosphate kinase B (NDP kinase B; NDKB) + nm23-H2S |
| 482 | C07f | 0.16709 | 0.81449 | 0.087157 | DNA primase small subunit; DNA primase 49-kDa subunit |
| 670 | D06l | 0.16745 | 1.2229 | 0.10486 | ephrin type-A receptor 5 precursor; tyrosine-protein kinase receptor EHK1; EPH homology kinase-1; HEK7 |
| 519 | C10a | 0.16794 | 1.4702 | 0.22163 | tumor necrosis factor receptor 1-associated death domain protein (TNFR1-associated death domain protein; TRADD) |
| 216 | B02f | 0.16797 | 1.1628 | 0.076749 | KIAA0135 |
| 1060 | F06j | 0.16834 | 1.5174 | 0.24425 | phosphatidic acid phosphatase 2B |
| 1058 | F06h | 0.16838 | 2.4026 | 0.66232 | interferon-regulated resistance GTP-binding protein MXAB |
| 1046 | F05j | 0.16839 | 1.6066 | 0.28646 | "CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,6-sialyltransferase; beta-galactoside alpha-2,6-sialyltransferase (alpha-2,6-ST); sialyltransferase 1 (SIAT1); B-cell CD75 antigen" |
| 1084 | F08f | 0.16994 | 0.63533 | 0.17324 | type I cytoskeletal 18 keratin; cytokeratin 18 (K18) |
| 28 | A02n | 0.17144 | 1.1778 | 0.08495 | growth inhibitory factor; metallothionein-III (MT-III) |
| 838 | E04l | 0.17147 | 0.85253 | 0.070476 | major histocompatibility complex encoded proteasome subunit LMP2 |
| 398 | C01f | 0.17255 | 0.65245 | 0.16678 | activator 1 40-kDa subunit; replication factor C 40-kDa subunit (RFC40); RFC2 |
| 966 | E13n | 0.173 | 1.1728 | 0.08306 | collagen 6 alpha 3 subunit (COL6A3) |
| 786 | E01b | 0.17463 | 0.71562 | 0.13756 | kidney epidermal growth factor (EGF); urogastrone |
| 473 | C06k | 0.17522 | 0.84134 | 0.076917 | interferon regulatory factor 1 (IRF1) |
| 880 | E07l | 0.17526 | 1.3499 | 0.16967 | ubiquitin-activating enzyme E1-related protein |
| 128 | A10b | 0.17534 | 1.3199 | 0.15514 | nucleoside diphosphate kinase A (NDKA); NDP kinase A; tumor metastatic process-associated protein; metastasis inhibition factor NM23 (NM23-H1) |
| 729 | D11a | 0.17594 | 0.76258 | 0.11541 | heterochromatin protein homolog 1 (HP1) |
| 384 | B14f | 0.17648 | 1.3676 | 0.17905 | mitogen-activated protein kinase kinase kinase (MAP kinase kinase kinase; MTK1) |
| 696 | D08j | 0.17657 | 0.8303 | 0.082688 | interferon-gamma (IFN-gamma) receptor beta subunit precursor; IFN-gamma accessory factor 1 (AF1); IFN-gamma transducer 1 (IFNGT1) |
| 552 | C12f | 0.17724 | 0.75843 | 0.118 | ataxia telangiectasia (ATM) |
| 704 | D09d | 0.17937 | 1.1996 | 0.098295 | alpha1 catenin (CTNNA1); cadherin-associated protein; alpha E-catenin |
| 1184 | G45 | 0.17941 | 0.6956 | 0.14991 | 23-kDa highly basic protein; 60S ribosomal protein L13A (RPL13A) |
| 572 | C13l | 0.17965 | 0.76893 | 0.1139 | muscarinic acetylcholine receptor M4 (CHRM4) |
| 589 | D01a | 0.18351 | 1.1921 | 0.096076 | guanine nucleotide-binding protein G(I) alpha 1 subunit (GNAI1); adenylate cyclase-inhibiting G alpha protein |
| 233 | B03i | 0.18448 | 1.2975 | 0.14929 | protein tyrosine phosphatase sigma |
| 686 | D07n | 0.18603 | 0.77225 | 0.11493 | neurotrophin-3 precursor (NT-3); neurotrophic factor (HDNF); nerve growth factor 2 (NGF-2) |
| 946 | E12h | 0.18671 | 0.63738 | 0.18345 | Wnt-2; int-1 related protein (IRP) |
| 1151 | F13c | 0.18816 | 0.71558 | 0.14465 | adenine phosphoribosyltransferase (APRT) |
| 538 | C11f | 0.18834 | 0.76805 | 0.11803 | DNA topoisomerase III (TOP3) |
| 187 | A14e | 0.18834 | 1.8518 | 0.43347 | H-ras proto-oncogene; transforming G protein |
| 364 | B12n | 0.18879 | 0.7043 | 0.15072 | insulin-like growth factor I receptor (IGF1R) |
| 1145 | F12k | 0.19115 | 0.74373 | 0.13173 | fau |
| 446 | C04l | 0.19166 | 0.7049 | 0.15197 | retinoic acid receptor alpha; retinoid X receptor alpha (RXRA) |
| 666 | D06h | 0.19193 | 0.76298 | 0.12218 | keratinocyte growth factor receptor (KGFR); fibroblast growth factor receptor 2 (FGFR2) + soluble KGFR + FGF-BEK; heparin-binding growth factor receptor K-sam (HGFR K-sam) + secreted FGFR K-sam-III + secreted FGFR K-sam-IV |
| 277 | B06k | 0.19276 | 1.2248 | 0.1162 | rho GDP dissociation inihibitor 2 (RHO GDI2; RHO-GDI beta); LY-GDI; ARHGDIB; GDID4 |
| 718 | D10d | 0.19358 | 1.6094 | 0.31599 | neural-cadherin precursor (N-cadherin; NCAD); cadherin 2 (CDH2) |
| 933 | E11i | 0.19508 | 0.78736 | 0.11084 | matrix metalloproteinase 12 (MMP12); metalloelastase |
| 71 | A06a | 0.19526 | 1.2401 | 0.12523 | moesin-ezrin-radixin-like protein (MERLIN); schwannomin (SCH); neurofibromatosis 2 (NF2) |
| 675 | D07c | 0.19534 | 1.3881 | 0.20249 | RAGE-4 ORF3 |
| 1136 | F12b | 0.196 | 1.1727 | 0.090327 | dopachrome tautomerase; dopachrome delta-isomerase |
| 927 | E11c | 0.19692 | 0.68915 | 0.16309 | insulin-like growth factor IA precursor (IGF1A); IGFBP1; somatomedin C + insulin-like growth factor I (IGF1) |
| 926 | E11b | 0.19728 | 1.5819 | 0.30569 | stem cell factor precursor (SCF); mast cell growth factor (MGF); c-kit ligand |
| 883 | E08a | 0.19782 | 0.61907 | 0.20049 | bone morphogenetic protein 6 precursor (BMP6) |
| 72 | A06b | 0.19828 | 1.2111 | 0.11129 | prohibitin (PHB) |
| 1024 | F04b | 0.19869 | 0.70936 | 0.15344 | heparan sulfate proteoglycan (HSPG2) |
| 59 | A05c | 0.19954 | 1.568 | 0.30076 | L-myc proto-oncogene (MYCL1) |
| 640 | D04j | 0.19967 | 1.5197 | 0.2753 | interferon-alpha/beta receptor alpha subunit precursor (IFN-alpha receptor; IFNAR) |
| 388 | B14j | 0.20022 | 1.2454 | 0.13026 | rho GDP dissociation inihibitor 1 (RHO-GDI 1); RHO-GDI alpha (GDIA1); ARHGDIA |
| 1074 | F07j | 0.20106 | 1.3336 | 0.17756 | probable protein disulfide isomerase ER-60 precursor (ERP60); 58-kDa microsomal protein; phospholipase C alpha |
| 418 | C02l | 0.20236 | 0.75358 | 0.13176 | p73 (monoallelically expressed p53-related protein) |
| 9 | A01i | 0.20241 | 1.3796 | 0.20299 | leukemia-associated gene 1 |
| 502 | C08l | 0.20252 | 0.80433 | 0.10467 | retinoic acid receptor alpha 1 (RAR-alpha 1; RARA) + PML-RAR protein |
| 1023 | F04a | 0.20283 | 0.70856 | 0.15608 | collagen 18 alpha 1 subunit (COL18A1) |
| 898 | E09b | 0.20496 | 0.63439 | 0.19723 | vascular endothelial growth factor precursor (VEGF); vascular permeability factor (VPF) |
| 247 | B04i | 0.20721 | 0.9066 | 0.050776 | phosphotyrosyl phosphatase activator |
| 968 | E14b | 0.20826 | 0.61258 | 0.21136 | keratinocyte growth factor (KGF); fibroblast growth factor 7 (FGF7) |
| 153 | A11m | 0.20879 | 1.4618 | 0.25241 | CDC16HS |
| 916 | E10f | 0.209 | 0.63528 | 0.19947 | interleukin-6 precursor (IL-6); B-cell stimulatory factor 2 (BSF2); interferon beta-2 (IFNB2); hybridoma growth factor |
| 156 | A12b | 0.20907 | 1.4564 | 0.24969 | LUCA15 putative tumor suppressor |
| 85 | A07a | 0.20986 | 1.2061 | 0.11304 | retinoblastoma-like protein 2 (RBL2; RB2); 130-kDa retinoblastoma-associated protein |
| 389 | B14k | 0.20992 | 0.80374 | 0.10767 | 51C protein (homology with inositol polyphosphate phosphatases) |
| 302 | B08h | 0.21097 | 1.3102 | 0.17076 | PTPCAAX1 nuclear tyrosine phosphatase (PRL-1) |
| 737 | D11i | 0.21121 | 1.2383 | 0.13132 | bone morphogenetic protein 4 type II receptor precursor (BMPR II) |
| 1082 | F08d | 0.21178 | 0.64618 | 0.19533 | multifunctional protein ADE2 |
| 937 | E11m | 0.21179 | 1.6976 | 0.38512 | MHC class I molecule + MHC class I subunit-related protein A (MICA); PERB11.1 |
| 772 | D14b | 0.21258 | 0.72917 | 0.14992 | T-cell surface glycoprotein E2 precursor; CD99 antigen; MIC2 protein |
| 497 | C08g | 0.21492 | 0.52986 | 0.26228 | mutL protein homolog; DNA mismatch repair protein MLH1; COCA2 |
| 1089 | F08k | 0.21523 | 0.77628 | 0.12494 | eukaryotic translation initiation factor 3 beta subunit (EIF-3 beta); EIF3 P116 |
| 1033 | F04k | 0.21557 | 0.77953 | 0.12326 | 60S ribosomal protein L5 |
| 900 | E09d | 0.21572 | 0.71792 | 0.15778 | B-cell growth factor 1 precursor (BCGF1); 12-kDa BCGF |
| 1056 | F06f | 0.21616 | 4.941 | 2.2076 | type I cytoskeletal 14 keratin; cytokeratin 14 (K14; CK14) |
| 565 | C13e | 0.21665 | 0.90876 | 0.051195 | proliferating cyclic nuclear antigen (PCNA); cyclin |
| 606 | D02d | 0.21672 | 0.67664 | 0.18148 | cadherin 5 (CDH5); vascular endothelial cadherin precursor (VE-cadherin); 7B4 antigen; CD144 antigen |
| 891 | E08i | 0.21758 | 1.2438 | 0.13724 | matrix metalloproteinase 7 (MMP7); matrilysin |
| 922 | E10l | 0.21789 | 1.6308 | 0.35537 | TAPASIN |
| 846 | E05f | 0.21818 | 0.60287 | 0.22395 | interleukin-2 precursor (IL-2); T-cell growth factor (TCGF) |
| 949 | E12k | 0.21853 | 2.0157 | 0.57342 | urokinase-type plasminogen activator precursor (U-plasminogen activator; UPA) |
| 487 | C07k | 0.21892 | 1.0607 | 0.03432 | NF-kappaB transcription factor p65 subunit; RELA; NFKB3 |
| 1123 | F11c | 0.21913 | 0.75434 | 0.13896 | uridine diphosphoglucose pyrophosphorylase; UTP-glucose-1-phosphate uridylyltransferase |
| 798 | E01n | 0.21929 | 0.702 | 0.16866 | unrearranged immunoglobulin V(H)5 pseudogene |
| 1119 | F10m | 0.22125 | 0.58536 | 0.23619 | interferon alpha-induced 11.5-kDa protein |
| 557 | C12k | 0.22277 | 0.82757 | 0.098707 | FHF-1 |
| 274 | B06h | 0.2231 | 0.75491 | 0.14045 | leukocyte antigen-related protein precursor (LAR) ; PTPRF + leukocyte surface CD47 antigen precursor; antigenic surface determinant protein OA3; integrin-associated protein (IAP) |
| 1098 | F09f | 0.2233 | 1.3258 | 0.18685 | type I cytoskeletal 19 keratin; cytokeratin 19 (K19; CK19) |
| 357 | B12g | 0.22355 | 1.2375 | 0.13628 | phosphorylase B kinase beta regulatory subunit |
| 830 | E04d | 0.22375 | 0.69753 | 0.1737 | erythropoietin |
| 1030 | F04h | 0.22518 | 0.85874 | 0.081495 | regulator of G protein signaling 4 (RGS4; RGP4) |
| 938 | E11n | 0.2264 | 1.0821 | 0.047556 | collagen 6 alpha 1 subunit (COL6A1) |
| 1066 | F07b | 0.22752 | 0.82652 | 0.10084 | Golgi alpha-mannosidase II |
| 50 | A04h | 0.22759 | 1.2465 | 0.14332 | neurogenic locus notch protein homolog 1 precursor (NOTCH1); translocation-associated notch protein (TAN1) |
| 171 | A13c | 0.22976 | 1.1487 | 0.087066 | fos-related antigen (FRA1) |
| 875 | E07g | 0.23234 | 0.61755 | 0.22576 | interleukin-9 precursor (IL-9); T-cell growth factor p40 |
| 74 | A06d | 0.23325 | 1.135 | 0.079935 | cot proto-oncogene |
| 1042 | F05f | 0.23356 | 2.0438 | 0.61854 | type I cytoskeletal 13 keratin; cytokeratin 13 (K13; CK13) + type I cytoskeletal 15 keratin; cytokeratin 15 (K15; CK15) + type I cytoskeletal 17 keratin; cytokeratin 17 (K17; CK17) |
| 386 | B14h | 0.23361 | 1.9928 | 0.58844 | KIAA0283 |
| 492 | C08b | 0.23498 | 0.81296 | 0.11134 | caspase-4 precursor (CASP4); ICH-2 protease; TX protease; ICE(REL)-II + caspase-5 precursor (CASP5); ICH-3 protease; TY protease; ICE(REL)-III |
| 516 | C09l | 0.23558 | 0.72915 | 0.16153 | transcription factor E2F5 |
| 576 | C14b | 0.23728 | 0.65395 | 0.20749 | caspase-7 precursor (CASP7); ICE-like apoptotic protease 3 (ICE-LAP3); apoptotic protease MCH-3; CMH-1 |
| 541 | C11i | 0.23736 | 0.88987 | 0.06605 | cyclic-AMP-dependent transcription factor atr-1; TREB36 protein |
| 320 | B09l | 0.23881 | 0.70524 | 0.17757 | 58-kDa inhibitor of the RNA-activated protein kinase |
| 595 | D01g | 0.24158 | 1.4034 | 0.24511 | neural cell adhesion molecule; CALL |
| 355 | B12e | 0.24216 | 1.1371 | 0.083492 | serine/threonine-protein kinase PCTAIRE 2 (PCTK2) |
| 444 | C04j | 0.24342 | 0.82025 | 0.10985 | BRCA1-associated ring domain protein |
| 286 | B07f | 0.2448 | 1.7104 | 0.43601 | trio |
| 975 | E14i | 0.24499 | 0.84243 | 0.096766 | matrix metalloproteinase 16 precursor (MMP16); membrane-type matrix metalloproteinase 3 (MT-MMP3); MMP-X2 |
| 669 | D06k | 0.24557 | 0.72429 | 0.16962 | tyrosine kinase receptor tie-1 precursor |
| 749 | D12g | 0.24643 | 1.3394 | 0.20934 | desmoglein 1 precursor (DSG1); desmosomal glycoprotein 1 (DG1) |
| 351 | B12a | 0.24892 | 1.347 | 0.2157 | growth factor receptor-bound protein 2 (GRB2) isoform; GRB3-3; SH2/SH3 adaptor GRB2; ASH protein + epidermal growth factor receptor-bound protein 2 (EGFRBP-GRB2) |
| 571 | C13k | 0.24942 | 2.7435 | 1.0854 | interferon regulatory factor 6 (IRF6) |
| 1183 | G43 | 0.25008 | 0.6437 | 0.22224 | cytoplasmic beta-actin (ACTB) |
| 316 | B09h | 0.25091 | 1.4246 | 0.26551 | protein phosphatase 2A B56-alpha |
| 1017 | F03i | 0.25139 | 0.8807 | 0.074715 | hemoglobin alpha subunit |
| 918 | E10h | 0.25213 | 0.6321 | 0.23092 | manic fringe |
| 409 | C02c | 0.25224 | 1.4425 | 0.27784 | BCL-2 binding athanogene-1 (BAG-1); glucocorticoid receptor-associated protein RAP46 |
| 848 | E05h | 0.25268 | 1.0979 | 0.061533 | beta-adrenergic receptor kinase 1 (beta-ARK1; BARK1; ADRBK1); G protein-coupled receptor kinase 2 (GRK2) |
| 1070 | F07f | 0.25337 | 2.2488 | 0.78681 | type I cytoskeletal 16 keratin; cytokeratin 16 (K16; CK16); pseudo-keratin K16 type I |
| 804 | E02f | 0.25381 | 0.84778 | 0.096031 | insulin-like growth factor-binding protein 3 precursor (IGF-binding protein 3; IGFBP3; IBP3) |
| 104 | A08f | 0.25384 | 1.2065 | 0.13026 | insulin-like growth factor binding protein 2 (IGFBP2) |
| 125 | A09m | 0.25447 | 1.1072 | 0.067758 | p53-dependent cell growth regulator CGR19 |
| 10 | A01j | 0.25482 | 2.0894 | 0.68937 | cyclin I |
| 1115 | F10i | 0.25662 | 0.62384 | 0.23932 | arginine/serine-rich splicing factor 7; splicing factor 9G8 |
| 63 | A05g | 0.25721 | 1.367 | 0.23392 | gamma-interferon-inducible protein; IP-30 |
| 206 | B01j | 0.25738 | 1.1428 | 0.091083 | GTP-binding protein ras associated with diabetes (RAD1) |
| 32 | A03d | 0.25836 | 1.2726 | 0.17434 | B-raf proto-oncogene (RAFB1) |
| 650 | D05f | 0.25945 | 1.4105 | 0.26338 | integrin alpha 9 (ITGA9); integrin alpha-RLC |
| 453 | C05e | 0.26083 | 1.4582 | 0.29521 | P53-BINDING PROTEIN 53BP1 |
| 725 | D10k | 0.26112 | 1.5993 | 0.38644 | lymphotoxin beta receptor precursor; tumor necrosis factor receptor 2-related protein; tumor necrosis factor C receptor |
| 1028 | F04f | 0.26235 | 1.421 | 0.27247 | type I cytoskeletal 12 keratin; cytokeratin 12 (K12) |
| 352 | B12b | 0.26284 | 1.284 | 0.1841 | JV18-1. HMAD-2 OR MADR2 OR SMAD2 |
| 212 | B02b | 0.26293 | 1.4088 | 0.26507 | NCK melanoma cytoplasmic src homolog (HSNCK) |
| 209 | B01m | 0.2654 | 0.64748 | 0.23023 | linker for activation of T-cells (LAT) |
| 467 | C06e | 0.26563 | 1.4599 | 0.30055 | CC3 (CC3) |
| 784 | D14n | 0.26622 | 0.69016 | 0.20285 | semaphorin |
| 181 | A13m | 0.26743 | 0.71374 | 0.18808 | retinoblastoma-binding protein 1 (RBP1) isoform I + isoform II |
| 1165 | F14c | 0.26765 | 0.76244 | 0.15618 | adenylosuccinate lyase; adenylosuccinase (ASL) |
| 405 | C01m | 0.26814 | 0.8266 | 0.11417 | zinc finger protein 22; KOX15 |
| 980 | E14n | 0.26817 | 0.73511 | 0.17442 | collagen 8 alpha 1 subunit (COL8A1) |
| 70 | A05n | 0.26948 | 0.91637 | 0.055283 | CDC37 homolog |
| 769 | D13m | 0.27015 | 1.3354 | 0.22213 | tyrosinase precursor; monophenol monooxygenase |
| 257 | B05e | 0.27063 | 0.91347 | 0.057389 | STE20-like kinase 3; MST3 |
| 885 | E08c | 0.27112 | 0.72873 | 0.18017 | platelet-derived growth factor A subunit precursor (PDGFA; PDGF1) |
| 1093 | F09a | 0.27222 | 0.78403 | 0.14391 | netrin-2 |
| 1020 | F03l | 0.27226 | 0.67508 | 0.21653 | KIAA0303 |
| 1018 | F03j | 0.2733 | 1.2495 | 0.16679 | 80-kDa nuclear cap-binding protein |
| 974 | E14h | 0.27428 | 0.74218 | 0.17283 | Wnt-8B |
| 223 | B02m | 0.27494 | 1.2125 | 0.14269 | hint protein; protein kinase C inhibitor 1 (PKCI1) |
| 582 | C14h | 0.27496 | 0.76321 | 0.15904 | damage-specific DNA binding protein p48 subunit (DDBB P48); implicated in xeroderma pigmentosum group E (DDB2) |
| 568 | C13h | 0.27594 | 1.0723 | 0.048688 | ALKB homolog protein |
| 138 | A10l | 0.27622 | 1.1379 | 0.092961 | cell division cycle protein 25A (CDC25A); M-phase inducer phosphatase 1 |
| 498 | C08h | 0.27642 | 0.78422 | 0.14555 | DNA mismatch repair protein MSH2 |
| 629 | D03m | 0.27655 | 1.6134 | 0.41393 | low-density lipoprotein receptor-related protein 1 precursor (LRP); alpha-2-macroglobulin receptor (A2MR); apolipoprotein E receptor (APOER); CD91 antigen |
| 1179 | G15 | 0.27711 | 0.81435 | 0.12548 | hypoxanthine-guanine phosphoribosyltransferase (HPRT) |
| 893 | E08k | 0.27822 | 1.331 | 0.22444 | bikunin; hepatocyte growth factor activator inhibitor 2 |
| 18 | A02d | 0.27875 | 1.2982 | 0.20251 | A-raf proto-oncogene serine/threonine-protein kinase; PKS2 |
| 236 | B03l | 0.27895 | 0.8392 | 0.10926 | "cAMP-dependent 3',5'-cyclic phosphodiesterase 4B (DPDE4); PDE32" |
| 837 | E04k | 0.27897 | 1.2566 | 0.17435 | PRSM1 metallopeptidase |
| 345 | B11i | 0.27925 | 0.68869 | 0.21171 | transforming protein rhoB; ARHB; ARH6 |
| 964 | E13l | 0.27943 | 2.315 | 0.89475 | HLA class II histocompatibility antigen alpha chain precursor |
| 822 | E03j | 0.27952 | 1.1724 | 0.11732 | cathepsin D precursor (CTSD) |
| 955 | E13c | 0.28016 | 0.71252 | 0.19602 | monocyte chemotactic protein 4 precursor (MCP4); monocyte chemoattractant protein 4; CK-beta10; NCC-1 |
| 1005 | F02k | 0.28076 | 0.85268 | 0.10062 | 40S ribosomal protein S5 |
| 981 | F01a | 0.28133 | 0.6772 | 0.22085 | collagen 11 alpha 1 subunit precursor (COL11A1) |
| 646 | D05b | 0.28197 | 0.89954 | 0.068859 | DNA-binding protein RFX5 |
| 450 | C05b | 0.28353 | 0.74192 | 0.17769 | death-associated protein 1 (DAP1) |
| 22 | A02h | 0.28366 | 1.4507 | 0.31043 | p53-induced protein |
| 912 | E10b | 0.28391 | 0.81581 | 0.12696 | pleiotrophin precursor (PTN) + osteoblast specific factor 1 (OSF-1) + heparin-binding neurite outgrowth promoting factor 1 (HBNF-1) ; heparin-binding growth-associated molecule (HB-GAM); heparin-binding growth factor 8 (HBGF-8) |
| 615 | D02m | 0.28514 | 2.0464 | 0.72381 | KIAA0407 |
| 75 | A06e | 0.28538 | 1.2662 | 0.18428 | proto-oncogene tyrosine-protein kinase abl; p150; c-abl |
| 524 | C10f | 0.28642 | 1.4536 | 0.31492 | DNA nucleotidylexotransferase; terminal addition enzyme; terminal deoxynucleotidyltransferase (TDT); terminal transferase; DNTT |
| 1156 | F13h | 0.28681 | 0.68382 | 0.21974 | importin beta 1 subunit; karyopherin beta 1 subunit; importin 90; nuclear factor p97 |
| 871 | E07c | 0.28802 | 0.67688 | 0.22534 | interferon gamma-induced protein precursor (gamma-IP10) |
| 1041 | F05e | 0.28986 | 1.0521 | 0.036524 | ornithine decarboxylase |
| 954 | E13b | 0.29067 | 0.76554 | 0.16475 | hepatocyte growth factor (HGF); scatter factor (SF); hepatopoeitin A |
| 387 | B14i | 0.29074 | 1.6694 | 0.47047 | vav oncogene |
| 20 | A02f | 0.29129 | 1.4555 | 0.32066 | N-ras; transforming p21 protein |
| 801 | E02c | 0.29171 | 0.70456 | 0.2082 | endothelin 2 (ET2) |
| 500 | C08j | 0.2928 | 0.88746 | 0.079556 | nuclear factor NF-kappa-B p100 subunit; nuclear factor NF-kappa-B p52 subunit; H2TF1; oncogene lyt-10 |
| 1120 | F10n | 0.29316 | 0.56336 | 0.30898 | zygini; FEZ1-T |
| 229 | B03e | 0.29326 | 1.1894 | 0.13404 | PKU-alpha |
| 977 | E14k | 0.29365 | 2.8957 | 1.3433 | hepatocyte growth factor-like protein (HGF activator-like protein); hyaluronan-binding protein (PHBP) |
| 965 | E13m | 0.29445 | 1.5768 | 0.40968 | immunoglobulin alpha 1 heavy chain constant region (IgA1; IGHA1) + immunoglobulin alpha 2 heavy chain constant region (IgA2; IGHA2) |
| 477 | C07a | 0.29478 | 1.4998 | 0.35534 | cytotoxic ligand TRAIL receptor |
| 113 | A09a | 0.29538 | 1.3094 | 0.22032 | retinoblastoma-associated protein (RB1); PP110; P105-RB |
| 197 | B01a | 0.29551 | 1.2703 | 0.19253 | high-affinity glutamate transporter; excitatory amino acid transporter 3; sodium-dependent glutamate/aspartate transporter 3; excitatory amino acid carrier 1 (EAAC1) |
| 201 | B01e | 0.29723 | 1.4695 | 0.3361 | ribosomal protein S6 kinase II alpha 3 (S6KII-alpha 3); ribosomal S6 kinase 2 (RSK2); insulin-stimulated protein kinase 1 (ISPK1) |
| 318 | B09j | 0.29877 | 0.81039 | 0.13632 | rho-related GTP-binding protein (RHOG); ARHG |
| 44 | A04b | 0.29915 | 1.4887 | 0.35168 | transforming growth factor-beta 3 (TGF-beta3) |
| 1065 | F07a | 0.29943 | 0.7443 | 0.18417 | laminin beta 1 subunit precursor (laminin B1; LAMB1) |
| 688 | D08b | 0.29976 | 0.72371 | 0.19918 | histone H4 |
| 751 | D12i | 0.29991 | 1.1518 | 0.10951 | fibroblast growth factor receptor 4 (FGFR4) |
| 340 | B11d | 0.30096 | 1.1259 | 0.091039 | cAMP-dependent protein kinase gamma-catalytic subunit (PKA C-gamma) |
| 116 | A09d | 0.30127 | 0.72737 | 0.19737 | c-kit proto-oncogene; mast/stem cell growth factor receptor precursor (SCFR); CD117 antigen |
| 129 | A10c | 0.30144 | 1.1974 | 0.14295 | elk-1; ets-related proto-oncogene |
| 91 | A07g | 0.30213 | 1.2179 | 0.15815 | matrix metalloproteinase 18 (MMP18) + MMP19 |
| 90 | A07f | 0.30257 | 1.5987 | 0.43498 | cell surface glycoprotein MUC18; melanoma-associated antigen A32; CD146 antigen; melanoma adhesion molecule |
| 533 | C11a | 0.30305 | 1.4868 | 0.35416 | caspase & rip adaptator with death domain (CRADD); rip-associated protein with death domain (RAIDD) |
| 397 | C01e | 0.3032 | 1.8679 | 0.6317 | seven in absentia homolog |
| 581 | C14g | 0.30389 | 1.2686 | 0.19591 | DNA-repair protein complementing XP-C cells; xeroderma pigmentosum group C complementing protein (p125) |
| 462 | C05n | 0.30456 | 0.85033 | 0.10935 | zinc finger protein |
| 935 | E11k | 0.30507 | 1.7013 | 0.51314 | bleomycin hydrolase (BLM hydrolase) |
| 360 | B12j | 0.30564 | 0.73871 | 0.19148 | ras-related C3 botulinum toxin substrate 2; p21-rac2; small G protein |
| 657 | D05m | 0.30724 | 2.0521 | 0.77448 | purinergic receptor P2Y5 |
| 621 | D03e | 0.30735 | 0.81585 | 0.13559 | integrin alpha 3 (ITGA3); galactoprotein B3 (GAPB3); VLA3 alpha subunit; CD49C antigen |
| 768 | D13l | 0.30915 | 1.3229 | 0.23891 | frizzled 5 |
| 259 | B05g | 0.30945 | 0.84145 | 0.11742 | serine/threonine protein kinase minibrain homolog; HP86; DYRK |
| 1080 | F08b | 0.30976 | 0.77031 | 0.17026 | UMK |
| 48 | A04f | 0.31033 | 1.3447 | 0.25589 | platelet-derived growth factor B subunit precursor (PDGFB; PDGF2); bacaplermin; c-sis |
| 716 | D10b | 0.31103 | 1.2616 | 0.19462 | nuclear autoantigen spreckled 100-kDa (SP100) |
| 1031 | F04i | 0.31201 | 1.1858 | 0.13859 | neutrophil gelatinase-associated lipocalin precursor (NGAL); 25-kDa alpha-2-microglobulin-related subunit of MMP9); lipocalin 2; oncogene 24P3 |
| 31 | A03c | 0.31213 | 0.88009 | 0.089465 | c-myc oncogene |
| 96 | A07l | 0.31288 | 1.5315 | 0.3974 | cyclin-dependent kinase 4 inhibitor D (CDKN2D); p19-INK4D |
| 362 | B12l | 0.31419 | 1.4463 | 0.33488 | STAT-induced STAT inhibitor 3 |
| 671 | D06m | 0.3156 | 1.4665 | 0.35139 | cytosolic superoxide dismutase 1 (SOD1) |
| 330 | B10h | 0.3166 | 1.2433 | 0.1838 | protein phosphatase 2A B56-beta (PP2A) |
| 219 | B02i | 0.31709 | 0.88255 | 0.088842 | protein phosphatase 2C gamma |
| 3 | A01c | 0.31912 | 1.5689 | 0.43271 | c-jun proto-oncogene; transcription factor AP-1 |
| 1174 | F14l | 0.3192 | 0.66706 | 0.2533 | adducin gamma subunit |
| 244 | B04f | 0.31931 | 1.2568 | 0.19543 | STE20-like kinase; MST2 |
| 29 | A03a | 0.32062 | 1.2707 | 0.20673 | tumor suppressor protein DCC precursor; colorectal cancer suppressor |
| 221 | B02k | 0.32083 | 0.89746 | 0.078363 | regulator of G protein signaling 14 (RGS14) |
| 815 | E03c | 0.32198 | 0.63871 | 0.27696 | hepatocyte growth factor-like protein; macrophage-stimulating protein (MSP) |
| 661 | D06c | 0.32238 | 1.2474 | 0.18989 | mesothelin precursor; CAK1 antigen |
| 787 | E01c | 0.32371 | 0.88824 | 0.086082 | brain-derived neurotrophic factor (BDNF) |
| 276 | B06j | 0.32415 | 1.432 | 0.33316 | Rho7 protein |
| 759 | D13c | 0.32472 | 0.75495 | 0.18926 | lymphoid-restricted membrane protein |
| 127 | A10a | 0.32476 | 1.2708 | 0.20918 | Von Hippel-Lindau tumor suppressor protein (VHL) |
| 752 | D12j | 0.32558 | 0.72266 | 0.2147 | IL-1RRP precursor |
| 317 | B09i | 0.326 | 0.81557 | 0.14294 | protein tyrosine phosphatase sigma |
| 545 | C11m | 0.32687 | 1.4118 | 0.31989 | putative regulatory protein TGF-beta-stimulated clone 22 homolog (TSC22) |
| 618 | D03b | 0.32796 | 1.9262 | 0.72169 | DNA-binding protein CPBP |
| 5 | A01e | 0.32799 | 1.2993 | 0.23319 | ERBB4 receptor protein-tyrosine kinase; Her4 tyrosine kinase-EGF receptor related |
| 443 | C04i | 0.32822 | 0.91277 | 0.06801 | endonuclease III homolog 1 (HNTH1) (OCTS3) |
| 40 | A03l | 0.32844 | 1.4912 | 0.38325 | checkpoint kinase 1 (CHK1) |
| 950 | E12l | 0.3286 | 1.8682 | 0.6776 | T cell receptor variable region |
| 878 | E07j | 0.32935 | 1.0764 | 0.059762 | protein C inhibitor (PROCI; PCI); plasma serine protease inhibitor precursor; plasminogen activator inhibitor 3 (PLANH3; PAI3) |
| 829 | E04c | 0.33097 | 0.7581 | 0.19002 | connective tissue growth factor precursor (CTGF) |
| 690 | D08d | 0.33221 | 0.83486 | 0.13016 | thrombospondin 2 precursor (THBS2; TSP2) |
| 802 | E02d | 0.33303 | 0.74788 | 0.19915 | NKG5 protein precursor; lymphokine LAG2; T-cell activation protein 519 |
| 225 | B03a | 0.33401 | 1.4339 | 0.34365 | specific 116-kDa vacuolar proton pump subunit |
| 515 | C09k | 0.33587 | 0.64195 | 0.285 | signal transducer and activator of transcription 2 (STAT2); p113 |
| 803 | E02e | 0.33589 | 0.59806 | 0.31996 | HGF agonist/antagonist |
| 296 | B08b | 0.33599 | 1.3872 | 0.30832 | smoothened; GX |
| 797 | E01m | 0.33765 | 0.8302 | 0.13581 | HLA class II histocompability antigen alpha subunit precursor (MHC-alpha) |
| 503 | C08m | 0.33802 | 1.1358 | 0.10871 | glucocorticoid receptor alpha variant |
| 921 | E10k | 0.33816 | 1.9029 | 0.72313 | chymotrypsin-like protease CTRL-1 precursor |
| 1125 | F11e | 0.33897 | 0.81508 | 0.14843 | DR-nm23 |
| 1146 | F12l | 0.33921 | 1.4499 | 0.36133 | BENE |
| 381 | B14c | 0.34066 | 1.1856 | 0.14966 | glycogen synthase kinase 3 beta (GSK3 beta); tau kinase subunit; factor A |
| 1010 | F03b | 0.34096 | 1.0921 | 0.07431 | fibronectin precursor (FN) |
| 425 | C03e | 0.34125 | 1.1484 | 0.11981 | TRAF-interacting protein (hTRIP) |
| 207 | B01k | 0.34206 | 0.80359 | 0.15896 | cytohesin-1; Sec7p-like protein |
| 245 | B04g | 0.34259 | 1.2117 | 0.17162 | testis-specific protein kinase 1 |
| 169 | A13a | 0.34319 | 1.3532 | 0.28675 | colorectal mutant cancer protein (MCC) |
| 271 | B06e | 0.34325 | 0.85751 | 0.11569 | KIAA0175 |
| 152 | A11l | 0.34482 | 1.1824 | 0.14869 | CDC25B; CDC25HU2; M-phase inducer phosphatase 2 |
| 77 | A06g | 0.34556 | 1.8362 | 0.68314 | matrix metalloproteinase 10 (MMP10); stromelysin 2 precursor (STMY2; SL2); transin 2 |
| 723 | D10i | 0.34577 | 1.2577 | 0.21067 | cytokine receptor class II CRF2-4 precursor |
| 902 | E09f | 0.34648 | 0.8015 | 0.16256 | interleukin-4 precursor (IL-4); B-cell stimulatory factor 1 (BSF-1); lymphocyte stimulatory factor 1 |
| 56 | A04n | 0.34706 | 1.7946 | 0.65173 | Bcl2 & p53 binding protein Bbp/53BP2 (BBP/53BP2) |
| 349 | B11m | 0.34723 | 0.82844 | 0.14078 | FKBP-rapamycin associated protein (FRAP); rapamycin target protein |
| 141 | A11a | 0.34992 | 1.3291 | 0.27199 | Wilms' tumor protein (WT33; WT1) |
| 1071 | F07g | 0.34995 | 3.5048 | 2.0704 | myosine light chain 1 slow-twitch muscle B/ventricular isoform (MLC1SB) |
| 578 | C14d | 0.35035 | 0.77639 | 0.18503 | PDCD2 |
| 554 | C12h | 0.35087 | 0.82687 | 0.14346 | RAD51C truncated protein |
| 676 | D07d | 0.35137 | 1.1423 | 0.1181 | integrin beta 8 precursor (ITGB8) |
| 971 | E14e | 0.35147 | 0.72802 | 0.22573 | dishevelled (DVL) + dishevelled 3 (DVL3) |
| 1108 | F10b | 0.35187 | 0.83917 | 0.13363 | IMP dehydrogenase 1 |
| 263 | B05k | 0.35271 | 1.2605 | 0.21693 | CDC42 GTPase-activating protein |
| 1078 | F07n | 0.35478 | 0.64235 | 0.29945 | GS2 protein |
| 728 | D10n | 0.35602 | 0.82209 | 0.14945 | secretogranin I precursor (SGI); chromogranin B |
| 708 | D09h | 0.3573 | 0.89044 | 0.092348 | cation-independent mannose-6-phosphate receptor precursor (CI man-6-P receptor; CI-MPR); insulin-like growth factor II receptor (IGFR II) |
| 326 | B10d | 0.3574 | 1.0936 | 0.078947 | cAMP-dependent protein kinase beta-catalytic subunit (PKA C-beta) |
| 573 | C13m | 0.35753 | 1.1696 | 0.14304 | nuclear protein SKIP |
| 205 | B01i | 0.35894 | 0.7945 | 0.17397 | protein-tyrosine phosphatase 1C (PTP1C); hematopoietic cell protein-tyrosine phosphatase; SH-PTP1 |
| 496 | C08f | 0.35964 | 0.74409 | 0.21705 | chromodomain-helicase-DNA-binding protein 1 (CHD1) |
| 694 | D08h | 0.36059 | 0.79232 | 0.17659 | N-sam; fibroblast growth factor receptor1 precursor (FGFR1); basic fibroblast growth factor receptor precursor (bFGFR); fms-like tyrosine kinase-2 (FLT2) + heparin-binding growth factor receptor (HBGF-R-alpha-A1) + HBGF-R-alpha-A2 + HBGF-R-alpha-A3 |
| 37 | A03i | 0.36093 | 1.2115 | 0.18003 | myelodysplasia/myeloid leukemia factor 2 (MLF2) |
| 338 | B11b | 0.36216 | 1.1895 | 0.16184 | GRB-IR / GRB10 |
| 1163 | F14a | 0.36321 | 1.2279 | 0.19513 | secreted protein acidic and rich in cysteine precursor (SPARC); osteonectin (ON); basement membrane protein (BM40) |
| 325 | B10c | 0.36417 | 1.1774 | 0.15226 | c-jun N-terminal kinase 2 (JNK2); JNK55 |
| 923 | E10m | 0.36568 | 1.2198 | 0.18942 | MHC class II HLA-DR-beta (DR2-DQW1/DR4 DQW3) precursor |
| 823 | E03k | 0.36695 | 1.5233 | 0.45248 | placental protein 11 precursor (PP11) |
| 162 | A12h | 0.36729 | 1.5126 | 0.44363 | cullin homolog 2 (CUL2) |
| 1009 | F03a | 0.36849 | 1.0762 | 0.066137 | collagen 16 alpha 1 subunit precursor (COL16A1) |
| 1047 | F05k | 0.36857 | 1.1494 | 0.12972 | 60S ribosomal protein L32 |
| 1061 | F06k | 0.36995 | 1.1695 | 0.14775 | translation initiation factor EIF-2B alpha subunit; EIF-2B GDP-GTP exchange factor |
| 1144 | F12j | 0.37038 | 0.89408 | 0.092422 | elongation factor 1 alpha (EF1 alpha) |
| 794 | E01j | 0.37099 | 0.84398 | 0.13635 | matrix metalloproteinase 13 (MMP13); collagenase 3 precursor |
| 188 | A14f | 0.37134 | 1.5639 | 0.49323 | p33ING1 |
| 95 | A07k | 0.37266 | 1.23 | 0.20185 | serine/threonine-protein kinase NEK3; NIMA-related protein kinase 3; HSPK 36 |
| 613 | D02k | 0.37321 | 0.80833 | 0.16849 | nuclear hormone receptor |
| 238 | B03n | 0.3751 | 0.76656 | 0.20623 | T3 receptor-associating cofactor 1 |
| 57 | A05a | 0.37689 | 1.2817 | 0.25002 | neurofibromatosis protein type I (NF1); neurofibromin |
| 843 | E05c | 0.37792 | 0.85412 | 0.12983 | teratocarcinoma-derived growth factor 1 (TDGF1); epidermal growth factor-like CRIPTO protein CR1; CRIPTO-1 growth factor (CRGF) + teratocarcinoma-derived growth factor 3 (TDGF3); epidermal growth factor-like CRIPTO protein CR3; CRIPTO-3 growth factor (CRG |
| 131 | A10e | 0.37799 | 2.3213 | 1.1761 | C-fes proto-oncogene |
| 793 | E01i | 0.37811 | 1.3097 | 0.2758 | Wnt-10B precursor; Wnt-12 |
| 192 | A14j | 0.37824 | 1.4994 | 0.44479 | CDC-like kinase 1 (CLK1) |
| 130 | A10d | 0.37853 | 1.2431 | 0.21669 | met proto-oncogene; hepatocyte growth factor receptor precursor (HGF-SF receptor) |
| 305 | B08k | 0.37863 | 1.0934 | 0.083284 | rho-GAP hematopoietic protein C1 (RGC1); KIAA0131 |
| 310 | B09b | 0.3791 | 0.84655 | 0.13699 | Putative rho/rac guanine nucleotide exchange factor (rho/rac GEF); faciogenital dysplasia protein (FGD1) |
| 332 | B10j | 0.38002 | 0.87059 | 0.11581 | Rho-related GTP-bindi |